| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Antonius Schuh last filed a Form 4 in January 2016, as CEO at CRDF. Antonius Schuh's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 20,000 shares of CRDF. Net of sales, the CRDF filings show accumulation of 20,000 shares.
Antonius Schuh has 2 Form 4 filings on record from August 2015 to January 2016, all as CEO at Cardiff Oncology (CRDF), 2015–2016.
The 2 reported transactions were 1 option or other derivative award and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $109K and no sales.
The only open-market purchase was 20,000 shares of CRDF at an average $5.45 on August 12, 2015, about $109K.
Shares as reported in the last Form 4 for each company; the most recent is from January 2016. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2015 | CRDF Cardiff Oncology, Inc. | CEO | Buy | 20,000 | $5.45 | $109,000.00 | New |